Correction: A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus. [PDF]
Cheng MH+10 more
europepmc +1 more source
Computable phenotypes to identify respiratory viral infections in the All of Us research program. [PDF]
Waxse BJ+5 more
europepmc +1 more source
Human Metapneumovirus Seasonality and Co-Circulation with Respiratory Syncytial Virus - United States, 2014-2024. [PDF]
Jobe NB+5 more
europepmc +1 more source
Detection of respiratory syncytial virus based on RT-RPA and CRISPR-Cas12a. [PDF]
Khamwut A+8 more
europepmc +1 more source
Clinical characteristics of single human rhinovirus infection and co-infection in the respiratory tract of children. [PDF]
Shi YR+6 more
europepmc +1 more source
Validation of oral-nasal specimen collection for influenza and respiratory syncytial virus detection. [PDF]
Young M+9 more
europepmc +1 more source
Assessment of physicians' perception of pediatrics respiratory syncytial virus disease and preferences for immunization strategies in the United States. [PDF]
Choi Y+6 more
europepmc +1 more source
Severe pneumomediastinum in an infant with respiratory syncytial virus infection: A case report. [PDF]
Egawa J+5 more
europepmc +1 more source
Respiratory Syncytial Virus Elicits Glycolytic Metabolism in Pediatric Upper and Lower Airways. [PDF]
Flores-Torres AS+5 more
europepmc +1 more source
Epidemiological trends and pathogen analysis of pediatric acute respiratory infections in Hanzhong Hospital, China: insights from 2023 to 2024. [PDF]
He Y+6 more
europepmc +1 more source